Nicholas Schwab

Department of Neurology with Institute of Translational Neurology, University Hospital Münster

Affiliated withUniversity Hospital Münster

Research Area

Biography

Nicholas Schwab has not added Biography.
If you are Nicholas Schwab and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 6	2017

Other Publications

Article	Year
Human myoblasts modulate the function of antigen-presenting cells. Journal of neuroimmunology\| PubMed ID: 18644633	2008
The cognitive and affective dimensions of moral conviction: implications for attitudinal and behavioral measures of interpersonal tolerance. Personality & social psychology bulletin\| PubMed ID: 18685130	2008
The co-inhibitory molecule PD-1 modulates disease severity in a model for an inherited, demyelinating neuropathy. Neurobiology of disease\| PubMed ID: 18996482	2009
CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain : a journal of neurology\| PubMed ID: 19179379	2009
PD-1 regulates neural damage in oligodendroglia-induced inflammation. PloS one\| PubMed ID: 19197390	2009
Intercellular exchanges of membrane fragments (trogocytosis) between human muscle cells and immune cells: a potential mechanism for the modulation of muscular immune responses. Journal of neuroimmunology\| PubMed ID: 19269695	2009
T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible. Journal of leukocyte biology\| PubMed ID: 19401389	2009
Accelerated course of experimental autoimmune encephalomyelitis in PD-1-deficient central nervous system myelin mutants. The American journal of pathology\| PubMed ID: 19443704	2009
Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood\| PubMed ID: 20215643	2010
An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 20357264	2010
FOXP3+ T regulatory cells in idiopathic inflammatory myopathies. Journal of neuroimmunology\| PubMed ID: 20537411	2010
Temporal pattern of ICAM-I mediated regulatory T cell recruitment to sites of inflammation in adoptive transfer model of multiple sclerosis. PloS one\| PubMed ID: 21085578	2010
Janus head: the dual role of HLA-G in CNS immunity. Cellular and molecular life sciences : CMLS\| PubMed ID: 21086150	2011
Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis. European journal of immunology\| PubMed ID: 21108477	2010
Immunological and clinical consequences of treating a patient with natalizumab. Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 21908480	2012
L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients. Neurology\| PubMed ID: 23925765	2013
CD4+NKG2D+ T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation. PloS one\| PubMed ID: 24282598	2013
Specific loss of cellular L-selectin on CD4+ T cells is associated with PML development during HIV infection. AIDS (London, England)\| PubMed ID: 24445368	2014
Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Annals of neurology\| PubMed ID: 24771567	2014
VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. The Journal of experimental medicine\| PubMed ID: 25135296	2014
Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis. International immunology\| PubMed ID: 25326459	2015
Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor). BMC neurology\| PubMed ID: 26099927	2015
Trafficking of lymphocytes into the CNS. Oncotarget\| PubMed ID: 26255669	2015
PML risk stratification using anti-JCV antibody index and L-selectin. Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 26432858	2016
Clustering of worry appraisals among college students. The Journal of social psychology\| PubMed ID: 26541710	2016
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values. Neurology(R) neuroimmunology & neuroinflammation\| PubMed ID: 26848486	2016
CD8(+) T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing. Nature communications\| PubMed ID: 27040081	2016
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 27162345	2016
Distinct pattern of lesion distribution in multiple sclerosis is associated with different circulating T-helper and helper-like innate lymphoid cell subsets. Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 27481205	2016
CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients. Neurology\| PubMed ID: 27572431	2016
B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 27671636	2016
Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease. Science translational medicine\| PubMed ID: 27797962	2016
CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy. Neurology\| PubMed ID: 27815407	2016
Natalizumab-associated PML: Challenges with incidence, resulting risk, and risk stratification. Neurology\| PubMed ID: 28228564	2017